AveXis aims to open Longmont plant by year end amid data probe
Note: listen to our discussion about Avexis and its wider impact on KUNC’s Colorado Edition. The segment begins at 12:20.
LONGMONT — AveXis Inc. plans to start producing gene-therapy drugs at the former AstraZeneca plant in Longmont at the end of the year, as regulators continue to scrutinize a data-manipulation scandal over its flagship drug.
The exterior of AveXis’ manufacturing building in Longmont. The drug producer plans to start making its flagship gene therapy by the end of 2019. Dan…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Nextera Healthcare LLC and ImagineMD have combined to form a single direct-primary-care organization for employer…
-
Electrasteel Inc., a developer of a more-sustainable iron and steel production process that does business…
-
Solid Power was selected this month by the U.S. Department of Energy to receive grant…
-
A gas station built in 1937 will reopen near Longmont’s Prospect neighborhood on Friday with…
